Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Molecular modeling of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile as a Dipeptidyl Peptidase IV (DPP4) Inhibitor

Muhammad Arba, Ruslin Ruslin, Nur Illiyyin Akib, Yamin Yamin, Sabarudin Ombe, Jessi Jessi, Muhammad Zakir Muzakkar, Daryono Hadi Tjahjono.




Abstract

Research on the quantitative structure activity relationship (QSAR) of the 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile as Dipeptidyl Peptidase IV (DPP4) inhibitor was performed. The molecular descriptors were calculated and best QSAR model was developed, which satisfied statistical parameters such as correlation coefficient R = 0.912 and leave-one-out validation coefficients q2 = 0.608. The predictive quality of the model was tested against test set compounds with R2pred value of 0.7057. A novel compound (ND1) was designed and its predicted IC50 was predicted, which was lower compared with that of parent compound (S24). Molecular docking and molecular dynamics simulation of 40 ns showed the stability of binding orientation of novel compound, parent compound, and native ligand of DPP4. Prediction of affinity using MM-PBSA method revealed that novel compound has comparable affinity with the parent and natural ligands.

Key words: dipeptidyl peptidase, carbonitril, qsar, docking, molecular dynamic simulation, MM-PBSA






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.